Development and validation of a nomogram for predicting endoscopic healing in crohn’s disease patients receiving infliximab treatment
Abstract Objective The objective of this study was to identify prognostic clinicopathological factors in patients with Crohn’s disease (CD) receiving infliximab (IFX) treatment and to develop a new nomogram for predicting outcomes in this population. Methods The primary outcome was endoscopic healin...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Gastroenterology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12876-025-04070-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849399893739700224 |
|---|---|
| author | Lixuan Li Ting Feng Xuanzhi Huang Xiaoman Zu Minhu Chen Yun Qiu |
| author_facet | Lixuan Li Ting Feng Xuanzhi Huang Xiaoman Zu Minhu Chen Yun Qiu |
| author_sort | Lixuan Li |
| collection | DOAJ |
| description | Abstract Objective The objective of this study was to identify prognostic clinicopathological factors in patients with Crohn’s disease (CD) receiving infliximab (IFX) treatment and to develop a new nomogram for predicting outcomes in this population. Methods The primary outcome was endoscopic healing (EH) in CD patients receiving IFX at week 30. Logistic regression models were employed to identify predictors of EH. Receiver operating characteristic analysis and calibration plots were used to assess the accuracy and clinical relevance of the developed nomogram. Results This retrospective study included 179 CD patients treated with IFX. Both univariate and multivariate logistic regression identified age (P =.059), platelet-lymphocyte ratio (PLR) (P =.001), anti-drug antibody concentration at 14 weeks (P =.005), IFX concentration at 14 weeks (P =.017) and C-reactive protein level at 14 weeks (P =.001) as independent predictors of EH. A nomogram was constructed based on these factors, its discrimination ability was assessed using area under the curve (AUC) in both the training cohort (N = 126) and validation cohort (N = 53), yielding an AUC of 0.828 (95% CI 0.757–0.899) and 0.731 (95% CI 0.593–0.869), respectively. Decision curve analysis demonstrated the nomogram’s clinical utility at risk thresholds above 0.13, with optimal utility between probabilities of 0.13 and 0.94. Conclusion This TDM- and PLR-based nomogram enables early identification of IFX responders, potentially reducing unnecessary endoscopic evaluations and guiding personalized therapy in CD management. |
| format | Article |
| id | doaj-art-18b06f32adee421e8873553e3f670648 |
| institution | Kabale University |
| issn | 1471-230X |
| language | English |
| publishDate | 2025-07-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Gastroenterology |
| spelling | doaj-art-18b06f32adee421e8873553e3f6706482025-08-20T03:38:13ZengBMCBMC Gastroenterology1471-230X2025-07-0125111010.1186/s12876-025-04070-zDevelopment and validation of a nomogram for predicting endoscopic healing in crohn’s disease patients receiving infliximab treatmentLixuan Li0Ting Feng1Xuanzhi Huang2Xiaoman Zu3Minhu Chen4Yun Qiu5Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen UniversityAbstract Objective The objective of this study was to identify prognostic clinicopathological factors in patients with Crohn’s disease (CD) receiving infliximab (IFX) treatment and to develop a new nomogram for predicting outcomes in this population. Methods The primary outcome was endoscopic healing (EH) in CD patients receiving IFX at week 30. Logistic regression models were employed to identify predictors of EH. Receiver operating characteristic analysis and calibration plots were used to assess the accuracy and clinical relevance of the developed nomogram. Results This retrospective study included 179 CD patients treated with IFX. Both univariate and multivariate logistic regression identified age (P =.059), platelet-lymphocyte ratio (PLR) (P =.001), anti-drug antibody concentration at 14 weeks (P =.005), IFX concentration at 14 weeks (P =.017) and C-reactive protein level at 14 weeks (P =.001) as independent predictors of EH. A nomogram was constructed based on these factors, its discrimination ability was assessed using area under the curve (AUC) in both the training cohort (N = 126) and validation cohort (N = 53), yielding an AUC of 0.828 (95% CI 0.757–0.899) and 0.731 (95% CI 0.593–0.869), respectively. Decision curve analysis demonstrated the nomogram’s clinical utility at risk thresholds above 0.13, with optimal utility between probabilities of 0.13 and 0.94. Conclusion This TDM- and PLR-based nomogram enables early identification of IFX responders, potentially reducing unnecessary endoscopic evaluations and guiding personalized therapy in CD management.https://doi.org/10.1186/s12876-025-04070-zCrohn’s diseaseInfliximabEndoscopic healingPlatelet lymphocyte ratio |
| spellingShingle | Lixuan Li Ting Feng Xuanzhi Huang Xiaoman Zu Minhu Chen Yun Qiu Development and validation of a nomogram for predicting endoscopic healing in crohn’s disease patients receiving infliximab treatment BMC Gastroenterology Crohn’s disease Infliximab Endoscopic healing Platelet lymphocyte ratio |
| title | Development and validation of a nomogram for predicting endoscopic healing in crohn’s disease patients receiving infliximab treatment |
| title_full | Development and validation of a nomogram for predicting endoscopic healing in crohn’s disease patients receiving infliximab treatment |
| title_fullStr | Development and validation of a nomogram for predicting endoscopic healing in crohn’s disease patients receiving infliximab treatment |
| title_full_unstemmed | Development and validation of a nomogram for predicting endoscopic healing in crohn’s disease patients receiving infliximab treatment |
| title_short | Development and validation of a nomogram for predicting endoscopic healing in crohn’s disease patients receiving infliximab treatment |
| title_sort | development and validation of a nomogram for predicting endoscopic healing in crohn s disease patients receiving infliximab treatment |
| topic | Crohn’s disease Infliximab Endoscopic healing Platelet lymphocyte ratio |
| url | https://doi.org/10.1186/s12876-025-04070-z |
| work_keys_str_mv | AT lixuanli developmentandvalidationofanomogramforpredictingendoscopichealingincrohnsdiseasepatientsreceivinginfliximabtreatment AT tingfeng developmentandvalidationofanomogramforpredictingendoscopichealingincrohnsdiseasepatientsreceivinginfliximabtreatment AT xuanzhihuang developmentandvalidationofanomogramforpredictingendoscopichealingincrohnsdiseasepatientsreceivinginfliximabtreatment AT xiaomanzu developmentandvalidationofanomogramforpredictingendoscopichealingincrohnsdiseasepatientsreceivinginfliximabtreatment AT minhuchen developmentandvalidationofanomogramforpredictingendoscopichealingincrohnsdiseasepatientsreceivinginfliximabtreatment AT yunqiu developmentandvalidationofanomogramforpredictingendoscopichealingincrohnsdiseasepatientsreceivinginfliximabtreatment |